We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02555397
Recruitment Status : Active, not recruiting
First Posted : September 21, 2015
Last Update Posted : March 3, 2022
Information provided by (Responsible Party):
Farzan Siddiqui, Henry Ford Health System

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : June 16, 2019
Estimated Study Completion Date : February 14, 2023